206 research outputs found
Robustness in Bayesian networks
This thesis explores the robustness of large discrete Bayesian networks (BNs) when applied in decision support systems which have a pre-specified subset of target variables. We develop new methodology, underpinned by the total variation distance, to determine whether simplifications which are currently employed in the practical implementation of such systems are theoretically valid. This versatile framework enables us to study the effects of misspecification within a Bayesian network (BN), and also extend the methodology to quantify temporal effects within Dynamic BNs. Unlike current robustness analyses, our new technology can be applied throughout the construction of the BN model; enabling us to create tailored, bespoke models. For illustrative purposes we shall be applying our work to the field of Food Security and a demonstrative ecological network
Recommended from our members
Assessment of the response of pollinator abundance to environmental pressures using structured expert elicitation
Policy-makers often need to rely on experts with disparate fields of expertise when making policy choices in complex, multi-faceted, dynamic environments such as those dealing with ecosystem services. For policy-makers wishing to make evidence-based decisions which will best support pollinator abundance and pollination services, one of the problems faced is how to access the information and evidence they need, and how to combine it to formulate and evaluate candidate policies. This is even more complex when multiple factors provide influence in combination. The pressures affecting the survival and pollination capabilities of honey bees (Apis mellifera), wild bees, and other pollinators are well documented, but incomplete. In order to estimate the potential effectiveness of various candidate policy choices, there is an urgent need to quantify the effect of various combinations of factors on the pollination ecosystem service. Using high-quality experimental evidence is the most robust approach, but key aspects of the system may not be amenable to experimentation or may be prohibitive based on cost, time and effort. In such cases, it is possible to obtain the required evidence by using structured expert elicitation, a method for quantitatively characterizing the state of knowledge about an uncertain quantity. Here we report and discuss the outputs of the novel use of a structured expert elicitation, designed to quantify the probability of good pollinator abundance given a variety of weather, disease, and habitat scenarios
Recommended from our members
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.
This review summarizes the last decade of work by the ENIGMA (Enhancing NeuroImaging Genetics through Meta Analysis) Consortium, a global alliance of over 1400 scientists across 43 countries, studying the human brain in health and disease. Building on large-scale genetic studies that discovered the first robustly replicated genetic loci associated with brain metrics, ENIGMA has diversified into over 50 working groups (WGs), pooling worldwide data and expertise to answer fundamental questions in neuroscience, psychiatry, neurology, and genetics. Most ENIGMA WGs focus on specific psychiatric and neurological conditions, other WGs study normal variation due to sex and gender differences, or development and aging; still other WGs develop methodological pipelines and tools to facilitate harmonized analyses of "big data" (i.e., genetic and epigenetic data, multimodal MRI, and electroencephalography data). These international efforts have yielded the largest neuroimaging studies to date in schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorder, substance use disorders, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism spectrum disorders, epilepsy, and 22q11.2 deletion syndrome. More recent ENIGMA WGs have formed to study anxiety disorders, suicidal thoughts and behavior, sleep and insomnia, eating disorders, irritability, brain injury, antisocial personality and conduct disorder, and dissociative identity disorder. Here, we summarize the first decade of ENIGMA's activities and ongoing projects, and describe the successes and challenges encountered along the way. We highlight the advantages of collaborative large-scale coordinated data analyses for testing reproducibility and robustness of findings, offering the opportunity to identify brain systems involved in clinical syndromes across diverse samples and associated genetic, environmental, demographic, cognitive, and psychosocial factors
National plans and awareness campaigns as priorities for achieving global brain health
Neurological conditions are the leading cause of death and disability combined. This public health crisis has become a global priority with the introduction of WHO's Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022â2031 (IGAP). 18 months after this plan was adopted, global neurology stakeholders, including representatives of the OneNeurology Partnership (a consortium uniting global neurology organisations), take stock and advocate for urgent acceleration of IGAP implementation. Drawing on lessons from relevant global health contexts, this Health Policy identifies two priority IGAP targets to expedite national delivery of the entire 10-year plan: namely, to update national policies and plans, and to create awareness campaigns and advocacy programmes for neurological conditions and brain health. To ensure rapid attainment of the identified priority targets, six strategic drivers are proposed: universal community awareness, integrated neurology approaches, intersectoral governance, regionally coordinated IGAP domestication, lived experience-informed policy making, and neurological mainstreaming (advocating to embed brain health into broader policy agendas). Contextualised with globally emerging IGAP-directed efforts and key considerations for intersectoral policy design, this novel framework provides actionable recommendations for policy makers and IGAP implementation partners. Timely, synergistic pursuit of the six drivers might aid WHO member states in cultivating public awareness and policy structures required for successful intersectoral roll-out of IGAP by 2031, paving the way towards brain health for all.</p
Microfabrication of a biomimetic arcade-like electrospun scaffold for cartilage tissue engineering applications
Designing and fabricating hierarchical geometries for tissue engineering (TE) applications is the major challenge and also the biggest opportunity of regenerative medicine in recent years, being the in vitro recreation of the arcade-like cartilaginous tissue one of the most critical examples due to the current inefficient standard medical procedures and the lack of fabrication techniques capable of building scaffolds with the required architecture in a cost and time effective way. Taking this into account, we suggest a feasible and accurate methodology that uses a sequential adaptation of an electrospinning-electrospraying set up to construct a system comprising both fibres and sacrificial microparticles. Polycaprolactone (PCL) and polyethylene glycol were respectively used as bulk and sacrificial biomaterials, leading to a bi-layered PCL scaffold which presented not only a depth-dependent fibre orientation similar to natural cartilage, but also mechanical features and porosity compatible with cartilage TE approaches. In fact, cell viability studies confirmed the biocompatibility of the scaffold and its ability to guarantee suitable cell adhesion, proliferation and migration throughout the 3D anisotropic fibrous network. Additionally, likewise the natural anisotropic cartilage, the PCL scaffold was capable of inducing oriented cell-material interactions since the morphology, alignment and density of the chondrocytes changed relatively to the specific topographic cues of each electrospun layer.publishe
DenseNet and Support Vector Machine classifications of major depressive disorder using vertex-wise cortical features
Major depressive disorder (MDD) is a complex psychiatric disorder that
affects the lives of hundreds of millions of individuals around the globe. Even
today, researchers debate if morphological alterations in the brain are linked
to MDD, likely due to the heterogeneity of this disorder. The application of
deep learning tools to neuroimaging data, capable of capturing complex
non-linear patterns, has the potential to provide diagnostic and predictive
biomarkers for MDD. However, previous attempts to demarcate MDD patients and
healthy controls (HC) based on segmented cortical features via linear machine
learning approaches have reported low accuracies. In this study, we used
globally representative data from the ENIGMA-MDD working group containing an
extensive sample of people with MDD (N=2,772) and HC (N=4,240), which allows a
comprehensive analysis with generalizable results. Based on the hypothesis that
integration of vertex-wise cortical features can improve classification
performance, we evaluated the classification of a DenseNet and a Support Vector
Machine (SVM), with the expectation that the former would outperform the
latter. As we analyzed a multi-site sample, we additionally applied the ComBat
harmonization tool to remove potential nuisance effects of site. We found that
both classifiers exhibited close to chance performance (balanced accuracy
DenseNet: 51%; SVM: 53%), when estimated on unseen sites. Slightly higher
classification performance (balanced accuracy DenseNet: 58%; SVM: 55%) was
found when the cross-validation folds contained subjects from all sites,
indicating site effect. In conclusion, the integration of vertex-wise
morphometric features and the use of the non-linear classifier did not lead to
the differentiability between MDD and HC. Our results support the notion that
MDD classification on this combination of features and classifiers is
unfeasible
The Apache Point Observatory Galactic Evolution Experiment (APOGEE)
The Apache Point Observatory Galactic Evolution Experiment (APOGEE), one of the programs in the Sloan Digital Sky Survey III (SDSS-III), has now completed its systematic, homogeneous spectroscopic survey sampling all major populations of the Milky Way. After a three-year observing campaign on the Sloan 2.5 m Telescope, APOGEE has collected a half million high-resolution (R ~ 22,500), high signal-to-noise ratio (>100), infrared (1.51â1.70 ÎŒm) spectra for 146,000 stars, with time series information via repeat visits to most of these stars. This paper describes the motivations for the survey and its overall designâhardware, field placement, target selection, operationsâand gives an overview of these aspects as well as the data reduction, analysis, and products. An index is also given to the complement of technical papers that describe various critical survey components in detail. Finally, we discuss the achieved survey performance and illustrate the variety of potential uses of the data products by way of a number of science demonstrations, which span from time series analysis of stellar spectral variations and radial velocity variations from stellar companions, to spatial maps of kinematics, metallicity, and abundance patterns across the Galaxy and as a function of age, to new views of the interstellar medium, the chemistry of star clusters, and the discovery of rare stellar species. As part of SDSS-III Data Release 12 and later releases, all of the APOGEE data products are publicly available
A meta-analysis of previous falls and subsequent fracture risk in cohort studies
NC Harvey acknowledges funding from the UK Medical Research Council (MC_PC_21003; MC_PC_21001). The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through 75N92021D00001, 75N92021D00002, 75N92021D00003, 75N92021D00004, and 75N92021D00005. Funding for the MrOS USA study comes from the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, and UL1 TR000128. Funding for the SOF study comes from the National Institute on Aging (NIA), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), supported by grants (AG05407, AR35582, AG05394, AR35584, and AR35583). Funding for the Health ABC study was from the Intramural research program at the National Institute on Aging under the following contract numbers: NO1-AG-6â2101, NO1-AG-6â2103, and NO1-AG-6â2106.Peer reviewedPostprin
- âŠ